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ABSTRACT
The Immuno Polymorphism Database (IPD), http://
www.ebi.ac.uk/ipd/ is a set of specialist databases
related to the study of polymorphic genes in the
immune system. The IPD project works with spe-
cialist groups or nomenclature committees who
provide and curate individual sections before they
are submitted to IPD for online publication. The
IPD project stores all the data in a set of related
databases. IPD currently consists of four databases:
IPD-KIR, contains the allelic sequences of killer-
cell immunoglobulin-like receptors, IPD-MHC, a
database of sequences of the major histocompati-
bility complex of different species; IPD-HPA,
alloantigens expressed only on platelets; and IPD-
ESTDAB, which provides access to the European
Searchable Tumour Cell-Line Database, a cell bank
of immunologically characterized melanoma cell
lines. The data is currently available online from
the website and FTP directory. This article describes
the latest updates and additional tools added to the
IPD project.
INTRODUCTION
The study of the immune system constitutes many differ-
ent complex areas of research. The Immuno
Polymorphism Database (IPD) is a set of specialist data-
bases related to the study of polymorphic genes of the
immune system. The IPD project works with specialist
groups and/or nomenclature committees, which each
curate a different section of the project. IPD currently
consists of four databases: IPD-KIR, currently contains
the allelic sequences of human killer-cell immunoglobulin-
like receptors (KIR); IPD-MHC, a database of sequences
of the major histocompatibility complex (MHC) of differ-
ent species; IPD-HPA, alloantigens expressed only on
platelets; and IPD-ESTDAB, which provides access to
the European Searchable Tumour Cell-Line Database
(ESTDAB), a cell bank of immunologically characterized
melanoma cell lines. By providing a centralized resource
for the work of different groups, it is hoped we can bring
together similar data to aid in the study and analysis of
this area. The IPD project stores all the data in a set
of related databases. Those sections with similar data,
IPD-KIR and IPD-MHC share the same database struc-
ture. The sharing of a common database structure makes
it easier to implement common tools for data submission
and retrieval. Other unrelated sections like IPD-ESTDAB
currently have their own unique structure.
IPD provides a large number of tools for the analysis of
KIR and non-human MHC sequences. These tools are
either custom written for the database or are incorporated
into existing tools on the European Bioinformatics
Institute (EBI) website, see Figure 1 (1,2).
These tools include the following:
. Sequence alignments: access to alignment tool, which
ﬁlters pre-generated alignments to the users’ speciﬁca-
tion. Provides alignments at the protein and level.
. Allele queries: access to detailed information on any
allele, including information on database cross-
references and seminal publications. This information
is also available through integration in the Sequence
Retrieval System service at EBI (3).
. Sequence similarity search tools: integration into
EBI’s suite of search tools including FASTA (4) and
BLAST (5).
. Downloads: access to a directory containing all the
data from the current and previous releases in a
variety of commonly used formats like FASTA,
MSF and PIR.
IPD-MHC
The MHC sequences of many different species have been
reported (6–17), along with different nomenclature
systems used in the naming and identiﬁcation of new
genes and alleles in each species (18). The sequences of
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the MHC from a number of different species are highly
conserved between species (19). The nomenclature for
MHC genes and alleles in species other than humans
(20,21) and mice (22,23) has historically been overseen
either informally by groups generating sequences, or by
formal nomenclature committees set up by the
International Society for Animal Genetics (ISAG) (24).
This work is now overseen by the Comparative MHC
Nomenclature Committee and is supported by ISAG
and the Veterinary Immunology Committee of the
International Union of Immunological Societies (25). By
bringing the work of different nomenclature committees
and the sequences of different species together, it is hoped
to provide a central resource that will facilitate further
research on the MHC of each species and on their com-
parison (26).
The ﬁrst version of the IPD-MHC database involved
the work of groups specializing in non-human primates
(NHP) (16), canines (DLA) (12) and felines (FLA) (27)
and incorporated all data previously available in the
IMGT/MHC database (26). Since the ﬁrst version, we
have been able to add sequences from cattle (BoLA)
(17), teleost ﬁsh (28), rats (RT1) (29), sheep (OLA) (15)
and swine (SLA) (14). In 2012, the nomenclature used to
Figure 1. The IPD Homepage provides access to the different IPD projects.
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describe the alleles of NHP was extensively revised and
updated (16). This was accompanied by updating the
IPD-MHC NHP section to complement the publication;
IPD-MHC NHP currently contains >4000 alleles covering
47 species of Apes, Old World and New World Monkeys.
The management of the sequences within IPD-MHC and
the provision of an online submission tool have enabled
these databases to grow, the number of sequences
increasing by at least 10% each year, and the nomencla-
ture to expand since the inclusion of a species within IPD.
This has resulted in regular publications reporting updates
or changes to the nomenclature (15–17,30).
IPD-KIR
The KIRs are members of the immunoglobulin super
family formerly called killer-cell inhibitory receptors.
KIRs have been shown to be highly polymorphic both
at the allelic and haplotypic levels (31). They are
composed of two or three Ig-domains, a transmembrane
region and cytoplasmic tail, which can in turn be short
(activatory) or long (inhibitory). The leukocyte receptor
complex, which encodes KIR genes, has been shown to be
polymorphic, polygenic and complex in a manner similar
to the MHC. Because of the complexity in the KIR region
and KIR sequences, a KIR Nomenclature Committee was
established in 2002, to undertake the naming of human
KIR allele sequences. The ﬁrst KIR Nomenclature report
was published in 2003 (32), which coincided with the ﬁrst
release of the IPD-KIR database. The number of ofﬁcially
named human KIR alleles has increased since the initial
release, which contained 89 alleles. As of September 2012,
there are >600 alleles, which code for >320 unique protein
sequences.
A recent development on the IPD-KIR website is online
tools to assist in the prediction of transplant outcome in
an unrelated haematopoetic stem cell transplant based on
the KIR content of the individuals involved. In 2008, a
tool was added to the website to help predict NK cell
alloreactivity based on the KIR ligands present in the
patient and donor, as transplant strategies based on
KIR-ligand mismatches had been shown to inﬂuence
relapse, graft versus host disease and survival in patients
with acute myeloid leukaemia (33). In 2010, with the goal
of developing a donor selection strategy to improve trans-
plant outcome, Cooley et al., (34) compared the contribu-
tion of KIR gene motifs with the clinical beneﬁt conferred
by donors with a particular haplotype. Donor KIR
genotype inﬂuenced transplantation outcome for some
forms of leukaemia, after a T-cell replete unrelated
donor transplant. KIR genotyping several HLA-matched
potential donors could substantially increase the fre-
quency of transplants using unrelated donor grafts with
favorable KIR gene content. To implement this strategy,
the IPD-KIR database was asked to provide an online
version of the algorithm described in the article, see
Figure 2. The B-Content calculator (http://www.ebi.ac.
uk/ipd/kir/donor_b_content.html) allows the user to
enter the KIR genotypes for up to ﬁve prospective
donors, and receive their B-Content assignments, and a
prediction result of the effect of the KIR genotype on
transplant outcome. To ensure only valid KIR genotypes
are submitted, all genotypes submitted are compared with
a list of predicted genotypes based on known KIR haplo-
types. In addition, this list has been supplemented with a
number of additional KIR genotypes that have been
deﬁned in routine KIR typing. If a prospective donor’s
KIR typing does not match any of the genotypes on this
list, a warning is issued.
In addition to allelic polymorphism, there is haplotypic
variability within the KIR region due to the different
number and kind of KIR genes. Haplotypic diversity is
a major contributor to the population diversity of KIR
and of cell repertoires. There are a number of fully
sequenced KIR haplotypes that have been reported
(35,36). The IPD-KIR website collates this data into a
graphic displaying the gene and allele content of these,
Figure 3. Where possible the alleles sequenced at the indi-
vidual KIR genes are also listed. Some genes are only
partially sequenced and for these an allele designation is
not provided. The graphic provides interactive links to the
individual allele entries, as well as details on the cell source
used for each haplotype.
The IPD-KIR database is also being expanded to include
the KIR sequences from other species, and most recently
work has begun on including the sequences of KIR alleles
found in Rhesus Macaques (Macaca mulatta) (37,38).
Work is also underway on a number of other species of
Macaques as well as Chimpanzees, Orangutans and
Domestic Cattle (39–42). The non-human KIR sequences
will be included into the IPD-KIR section and be accessible
using the same tools as the human KIR sequences.
Submission tools are already available for depositing
non-human KIRs into the database.
IPD-HPA
Human platelet antigens (HPA) are alloantigens expressed
only on platelets, speciﬁcally on platelet membrane glyco-
proteins. These platelet-speciﬁc antigens are immunogenic
and can result in pathological reactions to transfusion
therapy. The HPA nomenclature system was adopted in
1990 (43,44) to overcome problems with the previous no-
menclature. Since then, more antigens have been described
and the molecular basis of many has been resolved. As a
result, the nomenclature was revised in 2003 (45) and
included in the IPD project. The IPD-HPA section
contains nomenclature information and additional back-
ground material. The different genes in the HPA system
have not been sequenced to the same level as some of the
other projects and so currently only single-nucleotide
polymorphisms are used to determine alleles. This infor-
mation is presented in a grid of single-nucleotide poly-
morphisms for each gene. The IPD and HPA
nomenclature committee hope to expand this to provide
full sequence alignments when possible.
IPD-ESTDAB
IPD-ESTDAB is a database of immunologically
characterized melanoma cell lines. The database works
in conjunction with the European Searchable Tumour
Cell Line Database (ESTDAB) cell bank (46,47), which
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Figure 2. The B-Content Calculator allows you to enter the genotypes for up to ﬁve prospective donors and receive their assignments to one of
three groups based on KIR B-Content. The groups refer to the associated relapse protection seen in a T-cell replete Unrelated Donor Hematopoietic
Cell Transplant for Acute Myeloid Leukaemia.
Nucleic Acids Research, 2013, Vol. 41, Database issue D1237
 at U







is housed in Tu¨bingen, Germany and provides immuno-
logically characterized tumour cells. The IPD-ESTDAB
section of the website provides an online search facility
for cells stored in this cell bank. This enables investigators
to identify cells possessing speciﬁc parameters important
for studies of immunity, immunogenetics, gene expression,
metastasis, response to chemotherapy and other tumour
biological experimentation. The search tool allows for
searches based on a single parameter, or clusters of par-
ameters on >250 different markers for each cell. The
detailed reports produced can then be used to identify
cells of interest, which can be obtained from the cell bank.
OTHER DEVELOPMENTS
In 2012, the IMGT/HLA Database added an Extensible
Markup Language (XML) export to the data formats
available (20). XML is a simple but ﬂexible language
that deﬁnes a set of rules for encoding documents in a
format that is both human-readable and machine-
readable. Designed to meet the challenges of large-scale
electronic publishing, XML is playing an increasingly
important role in the exchange of scientiﬁc data. Work
is currently underway to also produce XML formatted
data ﬁles for the IPD-KIR and IPD-MHC database.
DISCUSSION
The IPD project provides a resource for those interested in
the study of polymorphic sequences in the immune system.
By accommodating related systems in a single database,
data can be made available in common formats aiding use
and interpretation. As the projects grow and more sections
are added, the beneﬁt of having expertly curated sequences
from related areas stored in a single location is becoming
more apparent. This is particularly true of the IPD-MHC
project, where cross-species studies are able to use the
high-quality sequences provided by the different nomen-
clature committees in a common standardized format,
ready for use. The initial release of the IPD Database
contained only four sections and a small number of
tools; however, as the database has grown and more
sections and species have been added, more tools have
been added to the website. We plan to use the existing
database structures to house data for new sections of the
IPD project as they become available. The ﬁles will also
be made available in different formats to download from
Figure 3. A selection of fully sequenced KIR haplotypes, the IPD-KIR website provides an interactive graphic that illustrates the gene composition
of a number of fully sequenced KIR haplotypes.
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the website, FTP server and included different web









If you are interested in contributing to the project,
there are speciﬁc guidelines for the inclusion of new
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